HERPESELECT 1 AND 2 HSV IMMUNOBLOT IB0900G

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a 06 report with the FDA on 2007-12-17 for HERPESELECT 1 AND 2 HSV IMMUNOBLOT IB0900G manufactured by Focus Diagnostics, Inc..

Event Text Entries

[21755038] Focus diagnostics rec'd two complaints regarding the common band of the herpeselect immunoblot igg (ib0900g). The customer reported that the (b)(6) common antigen band appeared (b)(6) than the reading control band. Reduced reactivity of the common antigen band may lead to the inaccurate interpretation of a sample as (b)(6).
Patient Sequence No: 1, Text Type: D, B5


[21857876] During the (b)(4) clinical trail several samples were (b)(6) in immunoblot, but (b)(6) on two other methods (b)(6). The frequency of these samples was approx (b)(6) of the samples tested). Statistical analysis demonstrated that the kit lot performed within the confidence internal of the performance characteristics as defined in the package insert. Post clinical trial, two complaints were rec'd that the (b)(6) antigen band was lighter (b)(6) than the (b)(4) reading control band on the same kit lot of immunoblot used in the clinical trial. The initial investigation indicated that the clinical trial samples were early (b)(6) which later sero-converted to (b)(6). Therefore a mdr report was not filed. Add'l investigation found that this explanation did not account for all samples. Further investigation determined that multiple freeze-thaws of the common antigen contributed to the malfunction. To address the situation, the package insert for the product ib0900g was revised to include a retest warning. The immunoblot common antigen has been stored in single use aliquots. Mfg documents will be revised to restrict freeze thaws on antigen preps. A blended sera which mimics the less reactive common antigen band on affected lots has been added to the quality control panel and will be used to qualify antigen preparations and to release final product.
Patient Sequence No: 1, Text Type: N, H10


MAUDE Entry Details

Report Number2023365-2007-00003
MDR Report Key2304516
Report Source06
Date Received2007-12-17
Date of Report2007-12-05
Date of Event2007-04-25
Date Mfgr Received2011-02-20
Device Manufacturer Date2007-01-01
Date Added to Maude2011-10-28
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Health Professional3
Initial Report to FDA3
Report to FDA0
Event Location0
Manufacturer ContactCONSTANCE BRIDGES, DIRECTOR
Manufacturer Street10703 PROGRESS WAY
Manufacturer CityCYPRESS CA 90630
Manufacturer CountryUS
Manufacturer Postal90630
Manufacturer Phone7142201900
Single Use3
Remedial ActionNO
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NameHERPESELECT 1 AND 2 HSV IMMUNOBLOT
Generic NameIMMUNOBLOT
Product CodeLGC
Date Received2007-12-17
Model NumberIB0900G
Catalog NumberIB0900G
Lot Number063169
Device Expiration Date2007-12-31
OperatorOTHER
Device AvailabilityN
Device AgeDA
Device Eval'ed by MfgrY
Device Sequence No1
Device Event Key0
ManufacturerFOCUS DIAGNOSTICS, INC.
Manufacturer AddressCYPRESS CA 90630 US 90630


Patients

Patient NumberTreatmentOutcomeDate
10 2007-12-17

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.